相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tachikawa project for prevention of posttraumatic stress disorder with polyunsaturated fatty acid (TPOP): study protocol for a randomized controlled trial
Yutaka Matsuoka et al.
BMC PSYCHIATRY (2013)
Clinical Issues in Use of Atypical Antipsychotics for Depressed Patients
Chi-Un Pae et al.
CNS DRUGS (2013)
Oral scopolamine augmentation for major depression
Changsu Han et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2013)
Effect of omega-3 and ascorbic acid on inflammation markers in depressed shift workers in Shahid Tondgoyan Oil Refinery, Iran: a randomized double-blind placebo-controlled study
Farahnaz Khajehnasiri et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2013)
Oxidative/nitrosative stress and antidepressants: Targets for novel antidepressants
Seung-Yup Lee et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
A Randomized, Double-Blind Placebo-Controlled Trial of Oral Creatine Monohydrate Augmentation for Enhanced Response to a Selective Serotonin Reuptake Inhibitor in Women With Major Depressive Disorder
In Kyoon Lyoo et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: A randomized controlled trial
Janice K. Kiecolt-Glaser et al.
BRAIN BEHAVIOR AND IMMUNITY (2012)
Omega 3 Fatty Acids and Cardiovascular Outcomes Systematic Review and Meta-Analysis
Sradha Kotwal et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2012)
The early improvement of depressive symptoms as a potential predictor of response to antidepressants in depressive patients who failed to respond to previous antidepressant treatments. Analysis of naturalistic data
M. Bares et al.
EUROPEAN PSYCHIATRY (2012)
Early switch strategy in patients with major depressive disorder
Chi-Un Pae et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2012)
Can botulinum toxin improve mood in depressed patients?
Changsu Han et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2012)
Omega-3 Fatty Acid Treatment, With or Without Cytidine, Fails to Show Therapeutic Properties in Bipolar Disorder A Double-Blind, Randomized Add-on Clinical Trial
Beth L. Murphy et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Omega-3 Fatty Acid Augmentation of Citalopram Treatment for Patients With Major Depressive Disorder
Lev Gertsik et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
A Double-Blind, Placebo-Controlled Trial of Omega-3 Fatty Acids in Tourette's Disorder
Vilma Gabbay et al.
PEDIATRICS (2012)
Inflammation in psychopathology of depression: Clinical, biological, and therapeutic implications
Kuan-Pin Su
BIOMEDICINE-TAIWAN (2012)
Aripiprazole as Adjunctive Therapy for Patients with Major Depressive Disorder Overview and Implications of Clinical Trial Data
Chi-Un Pae et al.
CNS DRUGS (2011)
The Efficacy of Omega-3 Supplementation for Major Depression: A Randomized Controlled Trial
Francois Lesperance et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
The Impact of Omega-3 Fatty Acids on Depressive Disorders and Suicidality: Can We Reconcile 2 Studies With Seemingly Contradictory Results?
David Mischoulon
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Suicide Deaths of Active-Duty US Military and Omega-3 Fatty-Acid Status: A Case-Control Comparison
Michael D. Lewis et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Omega-3 fatty acids for major depressive disorder associated with the menopausal transition: a preliminary open trial
Marlene P. Freeman et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2011)
Phospholipase A2 and Cyclooxygenase 2 Genes Influence the Risk of Interferon-α-Induced Depression by Regulating Polyunsaturated Fatty Acids Levels
Kuan-Pin Su et al.
BIOLOGICAL PSYCHIATRY (2010)
A Meta-Analytic Review of Polyunsaturated Fatty Acid Compositions in Patients with Depression
Pao-Yen Lin et al.
BIOLOGICAL PSYCHIATRY (2010)
Eicosapentaenoic acid as an add-on to antidepressant medication for co-morbid major depression in patients with diabetes mellitus: A randomized, double-blind placebo-controlled study
M. Bot et al.
JOURNAL OF AFFECTIVE DISORDERS (2010)
Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression
Andre Tadic et al.
JOURNAL OF AFFECTIVE DISORDERS (2010)
Long-Chain Omega-3 Fatty Acids and Women's Mental Health in the Perinatal Period and Beyond
Kathleen Kendall-Tackett
JOURNAL OF MIDWIFERY & WOMENS HEALTH (2010)
Omega-3 Fatty Acids Reverse Age-Related Decreases in Nuclear Receptors and Increase Neurogenesis in Old Rats
Simon C. Dyall et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2010)
Docosahexaenoic Acid Suppresses Neuroinflammatory Responses and Induces Heme Oxygenase-1 Expression in BV-2 Microglia: Implications of Antidepressant Effects for Omega-3 Fatty Acids
Dah-Yuu Lu et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Quetiapine XR: Current status for the treatment of major depressive disorder
Chi-Un Pae et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
Omega-3 fatty acid deficiency increases constitutive pro-inflammatory cytokine production in rats: Relationship with central serotonin turnover
Robert K. McNamara et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2010)
Ethyl-eicosapentaenoic acid for the treatment of psychological distress and depressive symptoms in middle-aged women: a double-blind, placebo-controlled, randomized clinical trial
Michel Lucas et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials
J. Craig Nelson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2009)
Omega-3 Augmentation of Sertraline in Treatment of Depression in Patients With Coronary Heart Disease A Randomized Controlled Trial
Robert M. Carney et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression
Verena Henkel et al.
JOURNAL OF AFFECTIVE DISORDERS (2009)
Complementary and Alternative Medicine (CAM): Considerations for the Treatment of Major Depressive Disorder
Marlene P. Freeman
JOURNAL OF CLINICAL PSYCHIATRY (2009)
A Double-Blind, Randomized Controlled Trial of Ethyl-Eicosapentaenoate for Major Depressive Disorder
David Mischoulon et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Evidence for S-Adenosyl-L-Methionine (SAM-e) for the Treatment of Major Depressive Disorder
George I. Papakostas
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Increased Phospholipase A2 Activity and Inflammatory Response But Decreased Nerve Growth Factor Expression in the Olfactory Bulbectomized Rat Model of Depression: Effects of Chronic Ethyl-Eicosapentaenoate Treatment
Cai Song et al.
JOURNAL OF NEUROSCIENCE (2009)
EPA but Not DHA Appears To Be Responsible for the Efficacy of Omega-3 Long Chain Polyunsaturated Fatty Acid Supplementation in Depression: Evidence from a Meta-Analysis of Randomized Controlled Trials
Julian G. Martins
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2009)
Subchronic Alpha-Linolenic Acid Treatment Enhances Brain Plasticity and Exerts an Antidepressant Effect: A Versatile Potential Therapy for Stroke
Nicolas Blondeau et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Biological Mechanism of Antidepressant Effect of Omega-3 Fatty Acids: How Does Fish Oil Act as a 'Mind-Body Interface'?
Kuan-Pin Su
NEUROSIGNALS (2009)
PUFA induce antidepressant-like effects in parallel to structural and molecular changes in the hippocampus
Venugopal Reddy Venna et al.
PSYCHONEUROENDOCRINOLOGY (2009)
Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder
Shima Jazayeri et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2008)
Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial
Anne-Marie Rees et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2008)
A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder
David Mischoulon et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Omega-3 fatty acids and supportive psychotherapy for perinatal depression: A randomized placebo-controlled study
Marlene P. Freeman et al.
JOURNAL OF AFFECTIVE DISORDERS (2008)
Depression in Parkinson's disease: A double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation
Ticyana Moralez da Silva et al.
JOURNAL OF AFFECTIVE DISORDERS (2008)
Omega-3 fatty acids for major depressive disorder during pyegnancy: Results from a randomized, double-blind, placebo-controlled trial
Kuan-Pin Su et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Augmentation of antidepressants with atypical antipsychotics: A review of the current literature
Noah S. Philip et al.
JOURNAL OF PSYCHIATRIC PRACTICE (2008)
Omega-3 fatty acids on the forced-swimming test
Shih-Yi Huang et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
From inflammation to sickness and depression: when the immune system subjugates the brain
Robert Dantzer et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Decreased brain docosahexaenoic acid content produces neurobiological effects associated with depression: Interactions with reproductive status in female rats
Beth Levant et al.
PSYCHONEUROENDOCRINOLOGY (2008)
No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function:: a randomised controlled trial
Peter J. Rogers et al.
BRITISH JOURNAL OF NUTRITION (2008)
Effects of interferon-alpha on rhesus monkeys: A nonhuman primate model of cytokine-induced depression
Jennifer C. Felger et al.
BIOLOGICAL PSYCHIATRY (2007)
Omega-3 fatty acid eicosapentaenoic acid. A new treatment for psychiatric and neurodegenerative diseases: a review of clinical investigations
Cai Song et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Fish oil supplementation in the treatment of major depression: A randomised double-blind placebo-controlled trial
Brin F. S. Grenyer et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Tolerability of omega-3 fatty acid supplements in perinatal women
Marlene P. Freeman et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2007)
Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?
Brian M. Ross et al.
LIPIDS IN HEALTH AND DISEASE (2007)
Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17
Hongwu Shen et al.
DRUG METABOLISM AND DISPOSITION (2007)
A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids
Pao-Yen Lin et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Preliminary in vivo evidence of increased N-acetyl-aspartate following eicosapentanoic acid treatment in patients with bipolar disorder
Sophia Frangou et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates
Tarique D. Perera et al.
JOURNAL OF NEUROSCIENCE (2007)
Omega-3 fatty acids upregulate adult neurogenesis
Barbara S. Beltz et al.
NEUROSCIENCE LETTERS (2007)
Safety considerations with omega-3 fatty acid therapy
Harold E. Bays
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Omega-3 fatty acid supplementation in patients with recurrent self-harm - Single-centre double-blind randomised controlled trial
Brian Hallahan et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
被撤回的出版物: n-3 oolyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism (Retracted article. See vol. 23, 2018)
J. S. Rao et al.
MOLECULAR PSYCHIATRY (2007)
Omega-3 fatty acids: Evidence basis for treatment and future research in psychiatry
Marlene P. Freeman et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Omega-3 fatty acids and perinatal depression: A review of the literature and recommendations for future research
M. P. Freeman
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2006)
Clinical overview of omacor: A concentrated formulation of omega-3 polyunsaturated fatty acids
Harold Bays
AMERICAN JOURNAL OF CARDIOLOGY (2006)
A meta-analysis of early sustained response rates between antidepressants and placebo for the treatment of major depressive disorder
GI Papakostas et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)
Red cell membrane omega-3 fatty acids are decreased in nondepressed patients with social anxiety disorder
P Green et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2006)
Docosahexaenoic acid promotes neurogenesis in vitro and in vivo
E. Kawakita et al.
NEUROSCIENCE (2006)
Cytokines sing the blues: inflammation and the pathogenesis of depression
CL Raison et al.
TRENDS IN IMMUNOLOGY (2006)
Omega-3 fatty acids are more beneficial in the depressive phase than in the manic phase in patients with bipolar I disorder
CC Chiu et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression
KM Silvers et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2005)
Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats
WA Carlezon et al.
BIOLOGICAL PSYCHIATRY (2005)
Dietary modulation of fatty acid profiles and oxidative status of rat henatocyte nodules: Eeffect of different n-6/n-3 fatty acid ratios
S Abel et al.
LIPIDS (2004)
Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain
S Ghelardoni et al.
BIOLOGICAL PSYCHIATRY (2004)
Comparative effects of eicosapentaenoic acid and docosahexaenoic acid on proliferation, cytokine production, and pleiotropic gene expression in Jurkat cells
R Verlengia et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2004)
Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats
A Wu et al.
JOURNAL OF NEUROTRAUMA (2004)
Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: Further evidence that lowered n-PUFAs are related to major depression
SR De Vriese et al.
LIFE SCIENCES (2003)
Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects
TA Mori et al.
FREE RADICAL BIOLOGY AND MEDICINE (2003)
Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil ω-3 fatty acids
DS Barbosa et al.
NUTRITION (2003)
Biological safety assessment of docosahexaenoic acid supplementation in a randomized clinical trial tor X-linked retinitis pigmentosa
DH Wheaton et al.
ARCHIVES OF OPHTHALMOLOGY (2003)
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
L Santarelli et al.
SCIENCE (2003)
Omega-3 fatty acids in major depressive disorder - A preliminary double-blind, placebo-controlled trial
KP Su et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2003)
The epidemiology of major depressive disorder - Results from the National Comorbidity Survey Replication (NCS-R).
RC Kessler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Increased lipid peroxidation during long-term intervention with high doses of n-3 fatty acids (PUFAs) following an acute myocardial infarction
H Grundt et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2003)
Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers
LE Rhodes et al.
CARCINOGENESIS (2003)
A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression
LB Marangell et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression
A Szegedi et al.
JOURNAL OF CLINICAL PSYCHIATRY (2003)
Polyunsaturated fatty acid deficit in patients with bipolar mania
CC Chiu et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2003)
Omega-3 fatty acids for depression in pregnancy
CC Chiu et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Omega-3 fatty acid treatment of women with borderline personality disorder: A double-blind, placebo-controlled pilot study
MC Zanarini et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
A dose-ranging study of the, effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs
M Peet et al.
ARCHIVES OF GENERAL PSYCHIATRY (2002)
Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder?
SI Rapoport et al.
ARCHIVES OF GENERAL PSYCHIATRY (2002)
Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder
B Nemets et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Polyunsaturated fatty acids and cerebral function: Focus on monoaminergic neurotransmission
S Chalon et al.
LIPIDS (2001)
Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids:: a possible common effect of mood stabilizers
MCJ Chang et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Docosahexaenoic acid accumulation in the prenatal brain -: Prooxidant and antioxidant features
E Yavin et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2001)
Short-term fish oil supplementation improved innate immunity, but increased ex vivo oxidation of LDL in man -: a pilot study
ME Turini et al.
EUROPEAN JOURNAL OF NUTRITION (2001)
The effect of n-3 fatty acids on coronary atherosclerosis: Results from SCIMO, an angiographic study, background and implications
C von Schacky et al.
LIPIDS (2001)
Susceptibility of LDL to oxidative modification in healthy volunteers supplemented with low doses of n-3 polyunsaturated fatty acids
S Higgins et al.
BRITISH JOURNAL OF NUTRITION (2001)
The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertrygliceridemia
AFH Stalenhoef et al.
ATHEROSCLEROSIS (2000)
Are ω3 fatty acids beneficial in depression but not mania?
KP Su et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Hypomania associated with ω3 fatty acids
G Kinrys
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Effect of interferon-α on tyrosine hydroxylase and catecholamine levels in the brain of rats
T Kumai et al.
LIFE SCIENCES (2000)
Antioxidant status of surgical patients receiving TPN with an Ω-3-fatty acid-containing lipid emulsion supplemented with α-tocopherol
J Linseisen et al.
CLINICAL NUTRITION (2000)
Relationship between vitamin E requirement and polyunsaturated fatty acid intake in man: a review
EEJ Valk et al.
INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH (2000)
Effect of omega 3 fatty acids on oxidative stress in humans: GC-MS measurement of urinary F-2-isoprostane excretion
TA Mori et al.
REDOX REPORT (2000)
分享论文
